Literature DB >> 19535414

Rastering strategy for screening and centring of microcrystal samples of human membrane proteins with a sub-10 microm size X-ray synchrotron beam.

Vadim Cherezov1, Michael A Hanson, Mark T Griffith, Mark C Hilgart, Ruslan Sanishvili, Venugopalan Nagarajan, Sergey Stepanov, Robert F Fischetti, Peter Kuhn, Raymond C Stevens.   

Abstract

Crystallization of human membrane proteins in lipidic cubic phase often results in very small but highly ordered crystals. Advent of the sub-10 microm minibeam at the APS GM/CA CAT has enabled the collection of high quality diffraction data from such microcrystals. Herein we describe the challenges and solutions related to growing, manipulating and collecting data from optically invisible microcrystals embedded in an opaque frozen in meso material. Of critical importance is the use of the intense and small synchrotron beam to raster through and locate the crystal sample in an efficient and reliable manner. The resulting diffraction patterns have a significant reduction in background, with strong intensity and improvement in diffraction resolution compared with larger beam sizes. Three high-resolution structures of human G protein-coupled receptors serve as evidence of the utility of these techniques that will likely be useful for future structural determination efforts. We anticipate that further innovations of the technologies applied to microcrystallography will enable the solving of structures of ever more challenging targets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19535414      PMCID: PMC2843980          DOI: 10.1098/rsif.2009.0142.focus

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  42 in total

1.  Characterization of conditions required for X-Ray diffraction experiments with protein microcrystals.

Authors:  R Glaeser; M Facciotti; P Walian; S Rouhani; J Holton; A MacDowell; R Celestre; D Cambie; H Padmore
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

2.  Diffraction-based automated crystal centering.

Authors:  Jinhu Song; Deepa Mathew; Sandhya A Jacob; Laura Corbett; Penjit Moorhead; S Michael Soltis
Journal:  J Synchrotron Radiat       Date:  2007-02-14       Impact factor: 2.616

3.  High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

Authors:  Vadim Cherezov; Daniel M Rosenbaum; Michael A Hanson; Søren G F Rasmussen; Foon Sun Thian; Tong Sun Kobilka; Hee-Jung Choi; Peter Kuhn; William I Weis; Brian K Kobilka; Raymond C Stevens
Journal:  Science       Date:  2007-10-25       Impact factor: 47.728

4.  The atomic structure of the bluetongue virus core.

Authors:  J M Grimes; J N Burroughs; P Gouet; J M Diprose; R Malby; S Ziéntara; P P Mertens; D I Stuart
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962

5.  Primary radiation damage of protein crystals by an intense synchrotron X-ray beam.

Authors:  T Y Teng; K Moffat
Journal:  J Synchrotron Radiat       Date:  2000-09-01       Impact factor: 2.616

6.  Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.

Authors:  Vsevolod Katritch; Kimberly A Reynolds; Vadim Cherezov; Michael A Hanson; Christopher B Roth; Mark Yeager; Ruben Abagyan
Journal:  J Mol Recognit       Date:  2009 Jul-Aug       Impact factor: 2.137

7.  In meso crystal structure and docking simulations suggest an alternative proteoglycan binding site in the OpcA outer membrane adhesin.

Authors:  Vadim Cherezov; Wei Liu; Jeremy P Derrick; Binquan Luan; Aleksei Aksimentiev; Vsevolod Katritch; Martin Caffrey
Journal:  Proteins       Date:  2008-04

8.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

9.  Stabilization of the human beta2-adrenergic receptor TM4-TM3-TM5 helix interface by mutagenesis of Glu122(3.41), a critical residue in GPCR structure.

Authors:  Christopher B Roth; Michael A Hanson; Raymond C Stevens
Journal:  J Mol Biol       Date:  2007-12-23       Impact factor: 5.469

10.  Will reduced radiation damage occur with very small crystals?

Authors:  Colin Nave; Mark A Hill
Journal:  J Synchrotron Radiat       Date:  2005-04-14       Impact factor: 2.616

View more
  95 in total

Review 1.  Ice breaking in GPCR structural biology.

Authors:  Qiang Zhao; Bei-li Wu
Journal:  Acta Pharmacol Sin       Date:  2012-01-30       Impact factor: 6.150

2.  LCP-Tm: an assay to measure and understand stability of membrane proteins in a membrane environment.

Authors:  Wei Liu; Michael A Hanson; Raymond C Stevens; Vadim Cherezov
Journal:  Biophys J       Date:  2010-04-21       Impact factor: 4.033

3.  Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV.

Authors:  Yi Zheng; Gye Won Han; Ruben Abagyan; Beili Wu; Raymond C Stevens; Vadim Cherezov; Irina Kufareva; Tracy M Handel
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

4.  Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators.

Authors:  Gaojie Song; Dehua Yang; Yuxia Wang; Chris de Graaf; Qingtong Zhou; Shanshan Jiang; Kaiwen Liu; Xiaoqing Cai; Antao Dai; Guangyao Lin; Dongsheng Liu; Fan Wu; Yiran Wu; Suwen Zhao; Li Ye; Gye Won Han; Jesper Lau; Beili Wu; Michael A Hanson; Zhi-Jie Liu; Ming-Wei Wang; Raymond C Stevens
Journal:  Nature       Date:  2017-05-17       Impact factor: 49.962

5.  5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology.

Authors:  Yao Peng; John D McCorvy; Kasper Harpsøe; Katherine Lansu; Shuguang Yuan; Petr Popov; Lu Qu; Mengchen Pu; Tao Che; Louise F Nikolajsen; Xi-Ping Huang; Yiran Wu; Ling Shen; Walden E Bjørn-Yoshimoto; Kang Ding; Daniel Wacker; Gye Won Han; Jianjun Cheng; Vsevolod Katritch; Anders A Jensen; Michael A Hanson; Suwen Zhao; David E Gloriam; Bryan L Roth; Raymond C Stevens; Zhi-Jie Liu
Journal:  Cell       Date:  2018-02-01       Impact factor: 41.582

6.  Structural Connection between Activation Microswitch and Allosteric Sodium Site in GPCR Signaling.

Authors:  Kate L White; Matthew T Eddy; Zhan-Guo Gao; Gye Won Han; Tiffany Lian; Alexander Deary; Nilkanth Patel; Kenneth A Jacobson; Vsevolod Katritch; Raymond C Stevens
Journal:  Structure       Date:  2018-01-27       Impact factor: 5.006

7.  Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography.

Authors:  Uwe Weierstall; Daniel James; Chong Wang; Thomas A White; Dingjie Wang; Wei Liu; John C H Spence; R Bruce Doak; Garrett Nelson; Petra Fromme; Raimund Fromme; Ingo Grotjohann; Christopher Kupitz; Nadia A Zatsepin; Haiguang Liu; Shibom Basu; Daniel Wacker; Gye Won Han; Vsevolod Katritch; Sébastien Boutet; Marc Messerschmidt; Garth J Williams; Jason E Koglin; M Marvin Seibert; Markus Klinker; Cornelius Gati; Robert L Shoeman; Anton Barty; Henry N Chapman; Richard A Kirian; Kenneth R Beyerlein; Raymond C Stevens; Dianfan Li; Syed T A Shah; Nicole Howe; Martin Caffrey; Vadim Cherezov
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

Review 8.  Structural biology of G protein-coupled receptors: new opportunities from XFELs and cryoEM.

Authors:  Andrii Ishchenko; Cornelius Gati; Vadim Cherezov
Journal:  Curr Opin Struct Biol       Date:  2018-03-16       Impact factor: 6.809

Review 9.  Serial Femtosecond Crystallography of G Protein-Coupled Receptors.

Authors:  Benjamin Stauch; Vadim Cherezov
Journal:  Annu Rev Biophys       Date:  2018-03-15       Impact factor: 12.981

10.  An Improved Strategy for Fluorescent Tagging of Membrane Proteins for Overexpression and Purification in Mammalian Cells.

Authors:  Mitra S Rana; Xiyu Wang; Anirban Banerjee
Journal:  Biochemistry       Date:  2018-11-27       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.